Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 5, 2014, Pages 555-560

  Qi, Peter ^a   Tsivian, Matvey ^a   Abern, Michael R ^a   Passoni, Niccolo M ^a   McGinley, Kathleen F ^a   Polascik, Thomas J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

African American; Oncological outcomes; Race; Renal cell carcinoma; Renal mass; Survival

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SPECIFIC SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHRECTOMY; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; PREDICTION; PRIORITY JOURNAL; RACE; RADICAL NEPHRECTOMY; RECURRENCE FREE SURVIVAL; TREATMENT OUTCOME; CARCINOMA, RENAL CELL; DISEASE FREE SURVIVAL; ETHNOLOGY; KIDNEY NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; UNITED STATES;

AFRICAN AMERICANS; AGED; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 84902553669     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.11.011     Document Type: Article

References (20)

1. Cancer Facts & Figures 2013. American Cancer Society; 2013.
2. Lipworth L., Tarone R.E., McLaughlin J.K. Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer 2011, 11:133.
3. Stafford H.S., Saltzstein S.L., Shimasaki S., Sanders C., Downs T.M., Sadler G.R. Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol 2008, 179:1704-1708.
4. Zini L., Perrotte P., Capitanio U., et al. Race affects access to nephrectomy but not survival in renal cell carcinoma. BJU Int 2009, 103:889-893.
5. Berndt S.I., Carter H.B., Schoenberg M.P., Newschaffer C.J. Disparities in treatment and outcome for renal cell cancer among older black and white patients. J Clin Oncol 2007, 20:3589-3595.
6. Vaishampayan U.N., Do H., Hussain M., Schwartz K. Racial disparity in incidence patterns and outcome of kidney cancer. Urology 2003, 62:1012-1017.
7. Chow W.H., Shuch B., Linehan W.M., Devesa S.S. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer 2013, 15:388-394.
8. Setiawan V.W., Stram D.O., Nomura A.M., Kolonel L.N., Henderson B.E. Risk factors for renal cell cancer: the multiethnic cohort. Am J Epidemiol 2007, 15:932-940.
9. Purdue M.P., Moore L.E., Merino M.J., et al. An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer 2013, 1:2640-2647.
10. Sankin A., Cohen J., Wang H., Macchia R.J., Karanikolas N. Rate of renal cell carcinoma subtypes in different races. Int Braz J Urol 2011, 37:29-32. [discussion 3-4].
11. Edge S.B.B., Compton D.R., Fritz C.C., Greene A.G., Trotti F.L. A kidney. AJCC cancer staging manual 2010, 479-489. Springer, New York. 7th ed.
12. Campbell S.C. Malignant renal tumors. Campbell-Walsh urology 2011, Vol. 2.Chapt 49:1413-1474. Philadelphia Elsevier Saunders. 10th ed.
13. Eggener S.E., Yossepowitch O., Pettus J.A., Snyder M.E., Motzer R.J., Russo P. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol 2006, 1:3101-3106.
14. Cheville J.C., Lohse C.M., Zincke H., Weaver A.L., Blute M.L. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003, 27:612-624.
15. Park H.S., Lloyd S., Decker R.H., Wilson L.D., Yu J.B. Limitations and biases of the Surveillance, Epidemiology, and End Results database. Curr Probl Cancer 2012, 36:216-224.
16. Clarke C.A., Glaser S.L., Dorfman R.F., Bracci P.M., Eberle E., Holly E.A. Expert review of non-Hodgkin's lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications. Cancer Epidemiol Biomarkers Prev 2004, 13:138-143.
17. Morrissey C., Martinez A., Zatyka M., et al. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Cancer Res 2001, 1:7277-7281.
18. Gonzalgo M.L., Yegnasubramanian S., Yan G., et al. Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis. Clin Cancer Res 2004, 1:7276-7283.
19. Wang S., Dorsey T.H., Terunuma A., Kittles R.A., Ambs S., Kwabi-Addo B. Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. Plos One 2012, 7:e37928.
20. Yaeger R., Avila-Bront A., Abdul K., et al. Comparing genetic ancestry and self-described race in african americans born in the United States and in Africa. Cancer Epidemiol Biomarkers Prev 2008, 17:1329-1338.